PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-01

Date Title Company
01-Feb-2024 Dermata to Present at the Emerging Growth Conference on February 7, 2024 AccessWire
01-Feb-2024 Retreat Behavioral Health Offers Free Virtual Workshops to Families and Friends of Patients AccessWire
01-Feb-2024 Ventegra Announces Its ‘Great Place to Work®’ Certification Businesswire
01-Feb-2024 Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023 Businesswire
01-Feb-2024 Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering Businesswire
01-Feb-2024 Thornton & Ross named UK Top Employer for second year running Thornton & Ross
01-Feb-2024 Clinigen’s NaviGATE programme shows a third of rare disease patients are not aware that they can access unlicensed medicines Clinigen 
01-Feb-2024 Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO Maxion Therapeutics
01-Feb-2024 NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline NeoPhore Limited
01-Feb-2024 Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis Vivet Therapeutics
01-Feb-2024 EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO EnteroBiotix
01-Feb-2024 NICE publishes guidance in England & Wales recommending Zynlonta® (loncastuximab tesirine) as an additional option for adults with relapsed or refractory diffuse large B-cell lymphoma or high-grade B-cell lymphoma Sobi
01-Feb-2024 ALMOST HALF OF PATIENTS REMAIN UNAWARE OF THE GOVERNMENT’S PHARMACY FIRST SERVICE Charac 
01-Feb-2024 Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board Lindus Health
01-Feb-2024 CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products AccessWire
01-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Feb-2024 New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval AccessWire
01-Feb-2024 Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 AccessWire
01-Feb-2024 Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer Businesswire
01-Feb-2024 Corporate Update on Clinical Evaluation of MedMira’s Products AccessWire